PedAM
Pediatric Disease Annotations & Medicines
| Disease | schizophrenia |
| Phenotype | C0020538|hypertension |
| Sentences | 5 |
| PubMedID- 20923919 | The prevalence of hypertension in schizophrenia is likely to be large, as demonstrated by two recent studies (daumit et al., 2008; smith et al., 2007) which reported high levels of untreated hypertension (34% and 50%, respectively). |
| PubMedID- 22986004 | schizophrenia is statistically associated with metabolic syndrome, hypertension, and migraine because they form a cluster of diseases with similar pathophysiology. |
| PubMedID- 24661388 | The cohorts varied in sample size (from hundreds to over half a million participants), in methodology and in the outcomes studied (height, overweight and obesity, glucose metabolism and diabetes, hypertension, metabolic syndrome, quality of life, schizophrenia, socioeconomic parameters etc.). |
| PubMedID- 21876442 | The objective of this crosssectional study was to estimate the prevalence of metabolic disorders and hypertension in patients with schizophrenia and to compare prevalence between patients treated with first-generation (fga) and second-generation (sga) antipsychotic drugs. |
| PubMedID- 26469976 | Recent evidence has shown that schizophrenia is closely associated with hypertension [3], metabolic syndrome [4], obesity [5], type 2 diabetes [3, 6], and dyslipidemia [3, 5]. |
Page: 1